Radiopharm Theranostics Limited (RADX)
NASDAQ: RADX · Real-Time Price · USD
4.270
-0.080 (-1.84%)
At close: Apr 30, 2026, 4:00 PM EDT
4.290
+0.020 (0.47%)
After-hours: Apr 30, 2026, 7:54 PM EDT
Radiopharm Theranostics Market Cap
Radiopharm Theranostics has a market cap or net worth of $48.39 million as of April 30, 2026. Its market cap has increased by 42.68% in one year.
Market Cap
48.39M
Enterprise Value
22.27M
1-Year Change
42.68%
Ranking
Category
Stock Price
$4.27
Market Cap Chart
Since November 25, 2021, Radiopharm Theranostics's market cap has decreased from $72.85M to $48.39M, a decrease of -33.57%. That is a compound annual growth rate of -8.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 48.39M | -18.12% |
| Dec 31, 2025 | 59.10M | 81.41% |
| Dec 31, 2024 | 32.58M | 73.79% |
| Dec 29, 2023 | 18.75M | -20.04% |
| Dec 30, 2022 | 23.45M | -67.78% |
| Dec 31, 2021 | 72.76M | -0.12% |
| Nov 25, 2021 | 72.85M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PDS Biotechnology | 56.37M |
| Cingulate | 55.24M |
| Instil Bio | 54.80M |
| MiNK Therapeutics | 54.48M |
| Entera Bio | 54.08M |
| Kezar Life Sciences | 53.71M |
| Metagenomi Therapeutics | 52.29M |
| Telomir Pharmaceuticals | 48.82M |